Broadly neutralizing antiviral antibodies.

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Viruses evolve to evade adaptive immune responses.
• High variability in viral glycoproteins was thought to prevent broad-spectrum antibody therapies or vaccines.
• Developing effective antiviral strategies against rapidly mutating viruses remains a challenge.

Purpose of the Study:

• To explore new approaches for isolating broadly neutralizing antiviral antibodies.
• To identify conserved epitopes on highly variable viruses for vaccine development.
• To advance antibody-based therapies and vaccines against challenging viral pathogens.

Main Methods:

• Interrogation of human memory B cells and plasma cells with high efficiency.
• Isolation of broadly neutralizing antiviral antibodies against HIV-1 and influenza virus.
• Identification of conserved viral epitopes targeted by these antibodies.

Main Results:

• Successful isolation of several broadly neutralizing antibodies against highly variable viruses.
• Identification of conserved epitopes that are potential targets for broad vaccine design.
• Demonstration of new tools for viral disease prophylaxis and therapy.

Conclusions:

• Broadly neutralizing antibodies can be developed against highly variable viruses.
• Conserved epitopes identified by these antibodies are crucial for broad vaccine design.
• Advances in B cell interrogation enable new strategies for combating viral infections and developing long-lasting vaccines.